CORC  > 中国医学科学院 北京协和医学院
Posttreatment squamous cell carcinoma antigen predicts treatment failure in patients with cervical squamous cell carcinoma treated with concurrent chemoradiotherapy
Wang Weiping; Liu Xiaoliang; Hou Xiaorong; Lian Xin; Liu Zhikai; Shen Jie; Sun Shuai; Yan Junfang; Miao Zheng; Wang Dunhuang
2019
关键词Cervical cancer Concurrent chemoradiotherapy Squamous cell carcinoma antigen
ISSN号1095-6859
DOI10.1016/j.ygyno.2019.09.003
URL标识查看原文
收录类别PUBMED
内容类型期刊论文
URI标识http://www.corc.org.cn/handle/1471x/6335460
专题中国医学科学院 北京协和医学院
推荐引用方式
GB/T 7714
Wang Weiping,Liu Xiaoliang,Hou Xiaorong,et al. Posttreatment squamous cell carcinoma antigen predicts treatment failure in patients with cervical squamous cell carcinoma treated with concurrent chemoradiotherapy[J],2019.
APA Wang Weiping.,Liu Xiaoliang.,Hou Xiaorong.,Lian Xin.,Liu Zhikai.,...&Hu Ke.(2019).Posttreatment squamous cell carcinoma antigen predicts treatment failure in patients with cervical squamous cell carcinoma treated with concurrent chemoradiotherapy..
MLA Wang Weiping,et al."Posttreatment squamous cell carcinoma antigen predicts treatment failure in patients with cervical squamous cell carcinoma treated with concurrent chemoradiotherapy".(2019).
个性服务
查看访问统计
相关权益政策
暂无数据
收藏/分享
所有评论 (0)
暂无评论
 

除非特别说明,本系统中所有内容都受版权保护,并保留所有权利。


©版权所有 ©2017 CSpace - Powered by CSpace